26 reports

  • 6.1 INTRODUCTION
  • FUNCTIONAL FOOD INGREDIENTS MARKET SIZE, BY TYPE, 2016-2023 (USD MILLION)

PREBIOTICS RESIST GASTRIC ACIDITY AND HYDROLYSIS CAUSED BY ENZYMES AND GASTROINTESTINAL ABSORPTION.

  • Mineral Supplement
  • United States
  • Market Size
  • Arla Foods
  • Cargill Inc.

One of the major reasons for the high bioavailability of organic minerals is that, unlike inorganic minerals, these do not interact with fiber, tannin, phytate, silicates, oxalate, or other minerals in the gastrointestinal tract.

  • Mineral Supplement
  • Pig
  • World
  • Alltech Inc.
  • Kemin Industries, Inc.

Apart from TMD, excessive chewing can cause gastrointestinal problems.

  • Mineral Supplement
  • Smoking Cessation
  • World
  • Market Size
  • Mondelez International, Inc.

THE MICROPEARLS SPRAY FREEZING TECHNOLOGY ALLOWS FOR THE TIMELY RELEASE OF THESE ## KEY NUTRIENTS THROUGHOUT AN ANIMAL' S GASTROINTESTINAL TRACT.

  • Mineral Supplement
  • North America
  • United States
  • World
  • Market Size

Nicotine gum can be used regularly (one piece of gum every ##-## hours for the first ## weeks, followed by one piece every ##-## hours for ## weeks, and then one piece every ##-## hours for ## weeks).

  • Smoking Cessation
  • United States
  • World
  • GlaxoSmithKline plc
  • Novartis AG
  • VITAMIN & MINERAL PREMIXES MARKET, BY FUNCTIONALITY

Q. ##.

  • Mineral Supplement
  • World
  • Market Size
  • Glanbia plc
  • Nutreco N.V.

MARKET ##.

  • Mineral Supplement
  • APAC
  • Japan
  • World
  • Demand

You can easily book an appointment with one online.

  • Mineral Supplement
  • World
  • Market Size
  • Alltech Inc.
  • Kemin Industries, Inc.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Mineral Supplement
  • China
  • Demand
  • Amway Corporation
  • Joincare Pharmaceutical Group Industry Co., Ltd.

You can easily book an appointment with one online.

  • Smoking Cessation
  • GlaxoSmithKline plc
  • ITC Limited
  • Pfizer Inc.
  • Reynolds American Inc.

Dietary fibers can act by changing the nature of the contents of the gastrointestinal tract and by changing how other nutrients and chemicals are absorbed.

  • Energy
  • Mineral Supplement
  • Vitamin
  • China
  • Demand

It is estimated that worldwide one in five men and one in three women are at risk of an osteoporotic fracture.

  • Mineral Supplement
  • World
  • Forecast
  • Quidel Corporation
  • Roche Group
  • 2014

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...

  • Gastrointestinal Drug
  • Mineral Supplement
  • Smoking Cessation
  • United States
  • GlaxoSmithKline plc

The subsidiary is focused on aging care, critical care & surgery, gastrointestinal function, and pediatrics.

  • Mineral Supplement
  • North America
  • United States
  • Demand
  • Market Size

Q. ##.

  • Mineral Supplement
  • United States
  • Cargill Inc.
  • Koninklijke DSM N.V.
  • Nutreco N.V.
  • SMALL MOLECULES TO ANTAGONIZE CHRNA4 AND CHRNB2 FOR NICOTINE ADDICTION - DRUG PROFILE

MAR ##, 2015: SUVEN LIFE SECURES ONE (##) PRODUCT PATENT EACH IN EURASIA AND ISRAEL The U. S.

  • Psychotic Disorder
  • Smoking Cessation
  • United States
  • World
  • Product Initiative
  • SMALL MOLECULES TO ANTAGONIZE CHRNA4 AND CHRNB2 FOR NICOTINE ADDICTION - DRUG PROFILE

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Smoking Cessation
  • Therapy
  • World
  • Product Initiative
  • Suven Life Sciences Ltd
  • SMALL MOLECULES TO ANTAGONIZE CHRNA4 AND CHRNB2 FOR NICOTINE ADDICTION - DRUG PROFILE

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Psychotic Disorder
  • Smoking Cessation
  • United States
  • Product Initiative
  • Suven Life Sciences Ltd
  • SMALL MOLECULES TO ANTAGONIZE CHRNA4 AND CHRNB2 FOR NICOTINE ADDICTION - DRUG PROFILE

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Psychotic Disorder
  • Smoking Cessation
  • United States
  • Product Initiative
  • Suven Life Sciences Ltd
  • NICOTINE - DRUG PROFILE

The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others.

  • Pharmaceutical
  • Smoking Cessation
  • United States
  • Product Initiative
  • Invion Limited

The prominent features of this report are - ##.

  • Cardiology
  • Mineral Supplement
  • Therapy
  • World
  • Product Initiative
  • NICOTINE BITARTRATE - DRUG PROFILE

The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others.

  • Pharmaceutical
  • Smoking Cessation
  • Therapy
  • United States
  • Product Initiative
  • Small Molecules to Antagonize CHRNA4 and CHRNB2 for Nicotine Addiction - Drug Profile

The molecules developed by Companies in Phase II, Phase I, IND/ CTA Filed, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Pharmaceutical
  • Smoking Cessation
  • United States
  • World
  • Product Initiative

After one week, Group ## continued with daily SL BPN/ NX and Group ## with weekly CAM2038 for the following ## weeks (Phase ##).

  • Opioid
  • Smoking Cessation
  • United States
  • Product Initiative
  • Omeros Corporation
  • Small Molecules to Antagonize CHRNA4 and CHRNB2 for Nicotine Addiction

The molecules developed by Companies in Phase II, Phase I, IND/ CTA Filed, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Psychotic Disorder
  • Smoking Cessation
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd

In general, it is assumed that prebiotics mainly increase the activity of lactobacilli and bifidobacteria in the gastrointestinal tract.

  • Mineral Supplement
  • Europe
  • European Union
  • World
  • Market Size